China's top companies call on Jones Day's Hong Kong-based lawyers to help raise capital, plan their expansion, and launch new technologies. Jones Day was the first U.S. law firm licensed to practice Hong Kong law (1996), and our Hong Kong Office has enabled clients to complete landmark transactions in these and other significant business matters for more than 30 years.
- Clients are served by our Hong Kong-based lawyers' experience in capital markets, dispute resolution, intellectual property and life sciences, leveraged finance, M&A, projects, private equity, and real estate.
- Our clients benefit from one of the most dynamic cross-border practices in the region, as recognized by Chambers Asia, Legal 500 Asia Pacific, Asia Business Law Journal, and China Business Law Journal, among others
- Our Hong Kong-based lawyers have trained in Australia, mainland China, England and Wales, Singapore, and the United States, among other major jurisdictions
- We understand and engage our clients in different languages, including English, French, German, Mandarin, Spanish, Japanese, and Korean, as well as Cantonese, Shanghainese, and Taiwanese
- We are active in the community, working with the Justice Centre Hong Kong, the Hong Kong Student Aid Society, Variety—the Children's Charity, and many other organizations
Our Work in China: On-the-Ground Support for International Clients
Intellectual Property in China
GenScript Biotech Corporation completes US$423.8 million IPO and spin-off of its subsidiary Legend Biotech Corporation; and US$24 million purchase of Ordinary Shares of Legend Biotech
Junshi and Lilly to develop and commercialize antibodies for prevention and treatment of COVID-19 coronavirus